Statistics
Publications
37
Citations
3.6K
H-Index
23
Active since
1993
Pierre‐Yves Michellys is an author at Genomics Institute of the Novartis Research Foundation specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1993–2023
37
37
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia, Cai‐Hong Yun, Eunyoung Park et al. · Nature · 2016 · 879 citations · Full text
Medicine, Oncology, Pharmacology +11
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
Luc Friboulet, Nanxin Li, Ryohei Katayama et al. · Cancer Discovery · 2014 · 842 citations · Full text
Medicine, Oncology, Pharmacology +15
Thomas H. Marsilje, Wei Pei, Bei Chen et al. · Journal of Medicinal Chemistry · 2013 · 412 citations · Full text
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain
Christian C. Lee, Yong Jia, Nanxin Li et al. · Biochemical Journal · 2010 · 179 citations
1–5 of 37